Sponsor:
Rutgers, The State University of New Jersey
Code:
NCT07349810
Conditions
Post Operative Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine 0.5% Injectable Solution
Ropivacaine 0.2% Injectable Solution
1.3% liposomal bupivacaine (Exparel)
ambIT Infusion Pump
Brief summary:
Conditions
Post Operative Pain
Study ID
NCT07349810
Start date
Jan 1, 2026
Status verified date
Jan, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Jun 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Treatment
Arms
experimental: Post-Operative: Continuous ropivacaine via Ambit pump
active comparator: Pre-Operative: Liposomal bupivacaine (Exparel)
Interventions
Bupivacaine 0.5% Injectable Solution
Ropivacaine 0.2% Injectable Solution
1.3% liposomal bupivacaine (Exparel)
ambIT Infusion Pump
Primary outcome measure
Central contacts
Locations
University Center for Ambulatory Surgery
Recruiting
Somerset, New Jersey, United States, 08873
Sponsor
Rutgers, The State University of New Jersey
Last update posted
Jan 21, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rutgers, The State University of New Jersey on 2026-01-21.